Loading data for MDXH — first visit, this takes a few seconds.
MDxHealth SA (MDXH)
NasdaqCM: MDXH
· Real-Time Price · USD
0.81
+0.35 (76.09%)
At close: Aug 14, 2026, 8:00 PM
0.71
-12.00%
After-hours: 7:59 PM
The price, the headline numbers and the latest news, in one place.
MDxHealth SA (MDXH) Stock Price, Analysis & Data
76.09% (1D)
No data available
| Bid | 0.75 |
| Market Cap | 41.5M |
| Revenue (ttm) | 114.02M |
| Net Income (ttm) | -36.43M |
| n/a | |
| -0.65 | |
| n/a | |
| -2.13 | |
| P/B (ttm) | -1.39 |
| P/S (ttm) | 0.36 |
| Earnings Date | Nov 12, 2026 |
| Ask | 1.05 |
| Volume | 324,055,659 |
| Avg. Volume (20D) | 727,260 |
| Open | 0.60 |
| Previous Close | 0.46 |
| Day's Range | 0.58 - 1.13 |
| 52-Week Range | 0.40 - 5.33 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MDXH
MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. The company's testing solutions include Confirm mdx for prostate cancer tissue test that validates epigenetic test that guides the detection of occult prostate cancer on a patient's previously biopsied negative tissue; ExoD, a non-invasive urine test to assess risk of having clinically prostate cancer; and...
Industry Diagnostics & Research
Sector Healthcare
IPO Date Nov 4, 2021
Employees 364
Stock Exchange NasdaqCM
Ticker Symbol MDXH
Website https://mdxhealth.com
Financial Performance
In 2025, MDxHealth SA's revenue was 107.88M, an increase of 19.8% compared to the previous year's 90.05M. Earnings were -33.52M, a decrease of -11.95%.
Financial StatementsEarnings Surprise
MDxHealth SA has released their quarterly earnings on Aug 13, 2026:
MDxHealth SA is scheduled to release its earnings on Nov 12, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2